Navigation Links
InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study of Diabetes Meeting
Date:9/30/2009

LOS ALTOS, Calif., Sept. 30 /PRNewswire/ -- InteKrin Therapeutics Inc. announced today positive results for INT131 in long term, high exposure preclinical safety studies. Data will be presented at the 45th Annual European Association for the Study of Diabetes Meeting in Vienna, Austria at 12:45 PM Thursday, October 1, 2009 by InteKrin Therapeutics' Chief Operating Officer, Linda Higgins, PhD, in a presentation "Chronic Cardiovascular Safety of INT131 Besylate, a Selective PPAR-gamma Modulator (SPPARM) in Rodents and Monkeys is Differentiated from TZD Full Agonists."

"Typical cardiovascular effects noted with PPAR-gamma full agonists in preclinical and clinical studies, such as weight gain, fluid retention, cardiac hypertrophy, and premature death were not observed in the 2-year studies in rats and mice, or in a 1-year study in cynomolgus monkeys even at the highest doses tested, which provided very high exposure multiples of the clinical exposure at efficacious doses," said Dr. Higgins. "Results are consistent with in vitro and in vivo studies and with clinical data demonstrating a SPPARM profile of INT131 having unique PPAR-gamma activating properties with minimal cardiovascular side effects."

"Chronic nonclinical safety studies of PPAR-gamma ligands have been highly predictive of clinical experience," noted Jeri El Hage, PhD, an expert in PPAR toxicology who served over 18 years in the Center for Drug Evaluation and Research (CDER) at the FDA. "INT131 displayed an unprecedented preclinical safety profile with no cardiac safety signals at exposure multiples far greater than other PPAR agonists tested to date."

The high cardiovascular safety margin validates the design of INT131 to minimize the safety and tolerability issues associated with full agonist PPAR-gamma agents while retaining the clinically proved anti-diabetic properties of PPAR-gamma. In addition, the 2-year rodent studies showed no evidence of
'/>"/>

SOURCE InteKrin Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131
2. InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study
3. InteKrin Therapeutics to Present at the 2009 American Diabetes Association Annual Meeting
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
7. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
9. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
10. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
11. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 6, 2015 Moerae Matrix, a clinical ... that target inflammation and fibrosis, today announced the ... as Chief Medical Officer. Dr. ... and programs, which include a pipeline of therapies ... conditions.  Bill is an accomplished strategist and scientist ...
(Date:7/6/2015)... DUBLIN and SOUTH SAN FRANCISCO, ... plc (NYSE: AGN ), a leading global pharmaceutical ... on developing novel treatments for dry eye disease, today ... which Allergan will acquire Oculeve in an all-cash transaction. ... Oculeve for a $125 million upfront payment and commercialization ...
(Date:7/5/2015)... Nihon University is pleased to announce ... Collaboration "Medicine Definitely Jumps Up with 8K" will ... Tokyo, Japan . Many experts on ... present their achievements and future prospects on progress ... with 8K technology. (Documentation: http://prw.kyodonews.jp/prwfile/release/M000079/201507031722/_prw_OA1fl_Xy4Q5W4x.pdf ...
Breaking Medicine Technology:Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2Allergan to Acquire Oculeve Dry Eye Disease Development Programs 2Allergan to Acquire Oculeve Dry Eye Disease Development Programs 3Allergan to Acquire Oculeve Dry Eye Disease Development Programs 4Nihon University to Host International Symposium on Medical-Engineering Collaboration 2Nihon University to Host International Symposium on Medical-Engineering Collaboration 3
... CHENGDU, China , June 28 ... biopharmaceutical company that specializes,in patented biopharmaceutical, modernized traditional Chinese ... product portfolio at,the 45th 2010 National New Special Drugs ... 8th , till July 10th . Tianyin,s portfolio ...
... SAN DIEGO , June 28 ADVENTRX Pharmaceuticals, ... added to the Russell Microcap® Index on June 25, 2010 , ... , , ... available only to companies listed on a national exchange, is consistent with ...
Cached Medicine Technology:Tianyin Promotes its Flagship Product Portfolio at the 45th 2010 National New Special Drugs Trade Fair in July at Beijing 2Tianyin Promotes its Flagship Product Portfolio at the 45th 2010 National New Special Drugs Trade Fair in July at Beijing 3ADVENTRX Added to Russell Microcap Index 2
(Date:7/6/2015)... ... 2015 , ... Diabetes affects many of us and the Glycemic Load and ... the majority of which are Type 2. However, eight million do not know they ... have prediabetes (abnormally high blood sugar levels). Without reductions in blood sugar levels and ...
(Date:7/6/2015)... ... ... The Path of Least Resistance: The Evolution of Capitalism and Politics in America ... the past 40 years. The book explores the evolution of the global economy and ... time capsule that chronicles the economic development of the United States — from its ...
(Date:7/5/2015)... ... July 06, 2015 , ... City Sports, the Boston-based specialty ... co-produce two training clinics for first-time triathletes this summer with ethos, the owner and ... on Thursday, July 9, at 6:00 p.m. at the North End Greenway. The event ...
(Date:7/5/2015)... , ... July 05, 2015 , ... ... products, announces the Weed Master, a landscaping invention that effectively removes weeds ... billion US dollars," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:7/5/2015)... ... July 05, 2015 , ... Doctors at the Swedish Cancer ... combination may one day change the outlook for people with pleural mesothelioma. Surviving Mesothelioma ... , Researchers report that five mesothelioma patients treated with 25Gy of radiation over ...
Breaking Medicine News(10 mins):Health News:115 Million in the U.S. could beat diabetes with the help of a new app 2Health News:New Book Brings Reveals The Repercussions Associated With The Global Economy 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 4Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 5Health News:New Mesothelioma Study Calls IMRT/Surgery Combo “Innovative and Promising”, According to Surviving Mesothelioma 2
... birth registration in certain parts of India is not satisfactory. ... still go unregistered . ,Two out of every five ... government planning purposes, Plan India, a non-governmental organisation (NGO) said. ... compulsory under the Registration of Births & Deaths (RBD) Act, ...
... Some people are unwilling or unable to stop smoking, but ... they smoke each day . ,After studying healthcare ... few reports that assessed methods aimed at helping people reduce ... of cigarettes delivers clear health benefits. ,The main effort ...
... small risk of sudden death when seated, and not only when ... Archives of Disease in Childhood , a British journal. ... unexpected deaths that occurred among infants up to the age of ... ,Of 508 fully investigated deaths, 17, or 3.3 percent, occurred in ...
... of almost a thousand no-sex-till-marriage organizations. Take for example ... beautiful teen Jami Waite, has been an emblem of ... a single operation in Longview, Texas, to become an ... and its not weird, Waite declares. , Yet, for ...
... to oil the wheels of retail-based medical clinics. Accordingly, ... operation of these clinics . They vouch that the ... and businesses to expand basic medical services. ... by CVS Caremark Corp. to open a retail clinic, ...
... Changes to the UK licensing laws have trebled the number ... reveals research in Emergency Medicine Journal . ,The ... the clock, took effect in November 2005. ,The ... of binge drinking and associated crime and disorder, and boost ...
Cached Medicine News:Health News:Millions of Births Still Go Unreported in India 2Health News:Reducing Smoking - Mixed Messages and Latest Findings 2Health News:Virginity Rules-Meant To Be Broken? 2Health News:Virginity Rules-Meant To Be Broken? 3Health News:Retail Health Clinics Start Shop 2Health News:UK Licensing Law Changes Have Trebled Overnight Alcohol Related Visits to Emergency Care 2
... The pharmaceutical subset of the ... 21 of the Code of ... and final rules published in ... updated regularly as released by ...
... measuring principle - Pupil Zone Imaging Method ... offers high accuracy and reliability in refraction ... measurement (3.3 mm) using a mire ring, ... 4 points, both of which offer reliable ...
The combination of new measuring principle - Pupil Zone Imaging Method - and unique technology - SLD - offers high accuracy and reliability in refraction measurement....
... The ISI Free-Standing upper extremity table ... and in-office procedures. This table features ... and an extra-durable, hour-glass shaped Lexan ... stable -- this table is our ...
Medicine Products: